136 related articles for article (PubMed ID: 37099979)
1. Post-operative PET/CT improves the detection of early recurrence of squamous cell carcinomas of the oral cavity.
Yu Y; Schöder H; Zakeri K; Chen L; Kang JJ; McBride SM; Tsai CJ; Gelblum DY; Boyle JO; Cracchiolo JR; Cohen MA; Singh B; Ganly I; Patel SG; Michel LS; Dunn L; Sherman EJ; Pfister DG; Wong RJ; Riaz N; Lee NY
Oral Oncol; 2023 Jun; 141():106400. PubMed ID: 37099979
[TBL] [Abstract][Full Text] [Related]
2. Survival benefit associated with postoperative PET-CT before adjuvant radiotherapy or chemoradiotherapy in patients with oral squamous cell carcinoma.
Li M; Xuan G; Gu H; Wu J; Wang Y
Int J Oral Maxillofac Surg; 2022 Nov; 51(11):1382-1388. PubMed ID: 35288010
[TBL] [Abstract][Full Text] [Related]
3. Beyond the
Subramaniam RM; Marcus C
AJR Am J Roentgenol; 2022 Feb; 218(2):384. PubMed ID: 34133207
[No Abstract] [Full Text] [Related]
4. Accurate preoperative staging with [
Chen S; Chen Z; Zou G; Zheng S; Zheng K; Zhang J; Huang C; Yao S; Miao W
Eur Radiol; 2022 Sep; 32(9):6070-6079. PubMed ID: 35352157
[TBL] [Abstract][Full Text] [Related]
5. Volume-based 18F-fluorodeoxyglucose positron emission tomography/computed tomography parameters correlate with delayed neck metastasis in clinical early-stage oral squamous cell carcinoma.
Yamakawa N; Nakayama Y; Ueda N; Yagyuu T; Tamaki S; Kirita T
Oral Radiol; 2023 Oct; 39(4):668-682. PubMed ID: 37081306
[TBL] [Abstract][Full Text] [Related]
6. Utility of 3-Month Surveillance F-18 FDG PET/CT in Surgically Resected Oral Squamous Cell Carcinoma.
Marquardt M; Anderson C; Ginader T; Parkhurst J; Pagedar N; Bayon R; Clamon G; Hoover A; Buatti J
Ann Otol Rhinol Laryngol; 2018 Mar; 127(3):185-191. PubMed ID: 29313371
[TBL] [Abstract][Full Text] [Related]
7. Utility of FDG PET in patients with squamous cell carcinomas of the oral cavity.
Kim SY; Roh JL; Kim JS; Ryu CH; Lee JH; Cho KJ; Choi SH; Nam SY
Eur J Surg Oncol; 2008 Feb; 34(2):208-15. PubMed ID: 17482789
[TBL] [Abstract][Full Text] [Related]
8. Hypoxic volume evaluated by
Sato J; Kitagawa Y; Watanabe S; Asaka T; Ohga N; Hirata K; Shiga T; Satoh A; Tamaki N
Int J Oral Maxillofac Surg; 2018 May; 47(5):553-560. PubMed ID: 29030021
[TBL] [Abstract][Full Text] [Related]
9. Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma.
Chaput A; Calais J; Robin P; Thureau S; Bourhis D; Modzelewski R; Schick U; Vera P; Salaün PY; Abgral R
Head Neck; 2017 Jun; 39(6):1155-1165. PubMed ID: 28263422
[TBL] [Abstract][Full Text] [Related]
10. 18F-FDG-PET/CT parameters as imaging biomarkers in oral cavity squamous cell carcinoma, is visual analysis of PET and contrast enhanced CT better than the numbers?
Kendi AT; Corey A; Magliocca KR; Nickleach DC; Galt J; Switchenko JM; El-Deiry MW; Wadsworth JT; Hudgins PA; Saba NF; Schuster DM
Eur J Radiol; 2015 Jun; 84(6):1171-6. PubMed ID: 25816993
[TBL] [Abstract][Full Text] [Related]
11. Clinical usefulness of 2-deoxy-2-[18F] fluoro-d-glucose-positron emission tomography/computed tomography for assessing early oral squamous cell carcinoma (cT1-2N0M0).
Yamaga E; Toriihara A; Nakamura S; Asai S; Fujioka T; Yoshimura R; Michi Y; Harada H; Tateishi U
Jpn J Clin Oncol; 2018 Jul; 48(7):633-639. PubMed ID: 29718274
[TBL] [Abstract][Full Text] [Related]
12. Laterality on FDG-PET/CT in clinically node-negative early-stage oral squamous cell carcinoma: a retrospective analysis of patients with late neck metastasis.
Minamitake A; Murakami R; Shiraishi S; Yoshida R; Sakata J; Hirosue A; Kawahara K; Yamana K; Nakayama H; Kitajima M; Sakamoto F
Oral Radiol; 2022 Jul; 38(3):438-442. PubMed ID: 35088222
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of preoperative 18F-FDG PET/CT for primary head and neck squamous cell carcinoma.
Joo YH; Yoo IeR; Cho KJ; Park JO; Nam IC; Kim CS; Kim MS
Eur Arch Otorhinolaryngol; 2014 Jun; 271(6):1685-91. PubMed ID: 23949547
[TBL] [Abstract][Full Text] [Related]
14. Clinical impact of PET/CT imaging after adjuvant therapy in patients with oral cavity squamous cell carcinoma.
Lin HC; Kang CJ; Huang SF; Wang HM; Lin CY; Lee LY; Liao CT; Yen TC
Eur J Nucl Med Mol Imaging; 2017 Sep; 44(10):1702-1711. PubMed ID: 28547178
[TBL] [Abstract][Full Text] [Related]
15. Use of Fluoro-[18F]-Deoxy-2-D-Glucose Positron Emission Tomography/Computed Tomography to Predict Immunotherapy Treatment Response in Patients With Squamous Cell Oral Cavity Cancers.
Shah H; Wang Y; Cheng SC; Gunasti L; Chen YH; Lako A; Guenette J; Rodig S; Jo VY; Uppaluri R; Haddad R; Schoenfeld JD; Jacene HA
JAMA Otolaryngol Head Neck Surg; 2022 Mar; 148(3):268-276. PubMed ID: 35050348
[TBL] [Abstract][Full Text] [Related]
16. Impact of a second FDG PET scan before adjuvant therapy for the early detection of residual/relapsing tumours in high-risk patients with oral cavity cancer and pathological extracapsular spread.
Liao CT; Fan KH; Lin CY; Wang HM; Huang SF; Chen IH; Kang CJ; Ng SH; Hsueh C; Lee LY; Lin CH; Yen TC
Eur J Nucl Med Mol Imaging; 2012 Jun; 39(6):944-55. PubMed ID: 22434050
[TBL] [Abstract][Full Text] [Related]
17. Targeting fibroblast activation protein in newly diagnosed squamous cell carcinoma of the oral cavity - initial experience and comparison to [
Linz C; Brands RC; Kertels O; Dierks A; Brumberg J; Gerhard-Hartmann E; Hartmann S; Schirbel A; Serfling S; Zhi Y; Buck AK; Kübler A; Hohm J; Lapa C; Kircher M
Eur J Nucl Med Mol Imaging; 2021 Nov; 48(12):3951-3960. PubMed ID: 34050405
[TBL] [Abstract][Full Text] [Related]
18. Postoperative PET/CT and target delineation before adjuvant radiotherapy in patients with oral cavity squamous cell carcinoma.
Dutta PR; Riaz N; McBride S; Morris LG; Patel S; Ganly I; Wong RJ; Palmer F; Schöder H; Lee N
Head Neck; 2016 Apr; 38 Suppl 1(Suppl 1):E1285-93. PubMed ID: 26335113
[TBL] [Abstract][Full Text] [Related]
19. The benefit of early PET/CT surveillance in HPV-associated head and neck squamous cell carcinoma.
Zhang I; Branstetter BF; Beswick DM; Maxwell JH; Gooding WE; Ferris RL
Arch Otolaryngol Head Neck Surg; 2011 Nov; 137(11):1106-11. PubMed ID: 22106234
[TBL] [Abstract][Full Text] [Related]
20. CT and FDG-PET radiologic biomarkers in p16+ oropharyngeal squamous cell carcinoma patients treated with definitive chemoradiotherapy.
Rosen BS; Wilkie JR; Sun Y; Ibrahim M; Casper KA; Miller JE; Chotchutipan T; Stucken CL; Bradford C; Prince MEP; Rosko AJ; Malloy KM; McLean SA; Chinn SB; Shuman AG; Spector ME; Swiecicki PL; Worden FP; Shah JL; Schonewolf CA; Chapman CH; Eisbruch A; Mierzwa ML
Radiother Oncol; 2021 Feb; 155():174-181. PubMed ID: 33069764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
